Reverse Fabry in Females Reveal Hidden Path to Relief
Financial Considerations and Access to Treatment
While treatments like ERT and pharmacological chaperones offer hope, they can be costly. The annual cost of ERT can range from $200,000 to $300,000, depending on the dosage and frequency required5. However, many insurance plans cover these treatments, and patient assistance programs are available to help manage costs.
For those seeking treatment, it's crucial to explore all available options, including clinical trials, which might offer access to cutting-edge therapies at reduced or no cost. Websites like ClinicalTrials.gov provide up-to-date information on ongoing studies and can be a valuable resource for those looking to participate in new treatment evaluations6.